Maryland Expands Phase 1 COVID Vaccine Eligibility For Severely Immunocompromised Marylanders
ANNAPOLIS (WJZ) — Maryland will expand Phase 1 eligibility for some immunocompromised Marylanders starting next week. The new groups added to Phase 1 starting February 1 include cancer patients in active treatment, end-stage renal disease requiring hemodialysis, chronic obstructive pulmonary disease, solid organ transplant patients–recipients– and those with sickle cell disease and diabetes.They will be able to get the vaccine through their hosp…
BIAS DISTRIBUTION
Maryland Expands Phase 1 COVID Vaccine Eligibility For Severely Immunocompromised Marylanders
ANNAPOLIS (WJZ) — Maryland will expand Phase 1 eligibility for some immunocompromised Marylanders starting next week. The new groups added to Phase 1 starting February 1 include cancer patients in active treatment, end-stage renal disease requiring hemodialysis, chronic obstructive pulmonary disease, solid organ transplant patients–recipients– and those with sickle cell disease and diabetes.They will be able to get the vaccine through their hosp…
Coverage analysis
Full Coverage
Articles
Maryland Expands Phase 1 COVID Vaccine Eligibility For Severely Immunocompromised Marylanders
ANNAPOLIS (WJZ) — Maryland will expand Phase 1 eligibility for some immunocompromised Marylanders starting next week. The new groups added to Phase 1 starting February 1 include cancer patients in active treatment, end-stage renal disease requiring hemodialysis, chronic obstructive pulmonary disease, solid organ transplant patients–recipients– and those with sickle cell disease and diabetes.They will be able to get the vaccine through their hosp…
Skin cancer vaccine developed by Tampa company enters Phase 1 of clinical trial
TAMPA, Fla. (WFLA) - A skin cancer vaccine developed by a Tampa company is entering "phase one" of clinical trials.Morphogenesis, Inc. completed its first-in-human phase one trial in cutaneous melanoma at Moffitt Cancer Center within the past year and has now moved into studying patients in earlier stages of skin cancers.The company will initiative phase one of the trial of "IFx-Hu2.0" for treating these stages. The vaccine contains a bacterial …